Simpler Grants.gov #FOR-AI-27-001

NIH Solicitation for Martin Delaney Collaboratories for HIV Cure Research

This opportunity from the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), seeks applications for the Martin Delaney Collaboratories for HIV Cure Research. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Program Objective: - Develop strategies to control HIV viral replication without lifelong antiretroviral therapy - Eradicate HIV reservoirs in both adults and children living with HIV - Collaboration Focus: - Encourages partnerships among academic institutions, government scientists, private sector entities, and community stakeholders - Leverages shared reagents, research resources, and specialized technologies - Products/Services Requested: - No specific OEMs, vendors, products, part numbers, or quantities are listed - Solicitation is for research proposals, not for procurement of goods or services - Unique Requirements: - Broad eligibility: educational institutions, government entities, businesses, and nonprofits - Approximately six awards expected - Estimated total funding: $20,000,000 - Cooperative agreement as the funding instrument

Description

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the Martin Delaney Collaboratories (MDCs) for HIV Cure Research. The goal of the MDC program is to develop strategies to control viral replication without lifelong antiretroviral therapy and ultimately eradicate HIV reservoirs. The program also addresses the unique needs of children living with HIV and fosters collaborations among academic institutions, government scientists, private sector, and community stakeholders. It leverages shared reagents, research resources, and specialized technologies to support basic, translational, and clinical research.

View original listing